ZIMMER BIOMET HOLDINGS, INC.
Ownership & governance
Executives 5Directors 10Avg age 59Avg tenure 7.6y
IT
Ivan Tornos
Chief Executive Officer
Age 51Since 2023-08-21Profile →
+14
Executives5
Board of directors10
AH
Arthur Higgins→
Director/Board Member
Age 70Since 2007-02-11
RH
Robert Hagemann→
Director/Board Member
Age 69Since 2008-03-12
BB
Betsy Bernard→
Director/Board Member
Age 70Since 2008-12-31
MF
Mick Farrell→
Director/Board Member
Age 53Since 2014-12-11
MH
Maria Hilado→
Director/Board Member
Age 61Since 2018-08-02
SJ
Syed Jafry→
Director/Board Member
Age 62Since 2018-08-02
IT
Ivan Tornos→
Chairman
Age 51Since 2025-05-28
SK
Sreelakshmi Kolli→
Director/Board Member
Age 51Since 2021-02-17
Shareholders5
| Name | Stake | Shares |
|---|---|---|
| Dodge & Cox | 12.17 % | 23,542,700 |
| Harris Associates LP | 6.699 % | 12,959,939 |
| Vanguard Capital Management LLC | 6.613 % | 12,793,412 |
| BlackRock Advisors LLC | 6.264 % | 12,118,745 |
| Capital Research & Management Co. (International Investors) | 4.714 % | 9,119,222 |
Catalog · 2026-07-09
Registry officers15
| Name | Role | Since | Shares |
|---|---|---|---|
| Ivan Tornos | Chairman | 2025-05-28 | - |
| Ivan Tornos | Chief Executive Officer | 2023-08-21 | - |
| Jonathan Vigdorchik | Chief Tech/Sci/R&D Officer | 2026-04-13 | - |
| Paul Stellato | Director of Finance/CFO | 2026-04-27 | - |
| Shaun Braun | Chief Tech/Sci/R&D Officer | 2024-09-30 | - |
| Arthur Higgins | Director/Board Member | 2007-02-11 | - |
| Betsy Bernard | Director/Board Member | 2008-12-31 | - |
| Devdatt Kurdikar | Director/Board Member | 2024-06-19 | - |
Registry · as of 2026-07-09
Group companies
| Name | Category |
|---|---|
| Zimmer Biomet Austria GmbH | Medical Specialties |
| Zimmer Biomet Austria GmbH | Medical Specialties |
| Zimmer Luxembourg II SARL | Financial Conglomerates |
| Zimmer Manufacturing BV | Financial Conglomerates |
| Zimmer Orthopedics Manufacturing Ltd. | Medical Specialties |
Institutional (13F)
Loading Form 13F holders…
Fund membership
Loading fund baskets…
Street consensus
Consensus buyMean target 106.82Range 93–130Analysts 22
93Mean 106.82130
- Strong buy 3
- Buy 6
- Hold 19
Broker actions40 of 390
| Firm | Action | To | Target | Date |
|---|---|---|---|---|
| Barclays | Initiated | Equal-Weight | 100 | 2026-10-07 |
| Canaccord Genuity | Maintained | Hold | 100 | 2026-08-10 |
| Truist Securities | Maintained | Hold | 106 | 2026-08-07 |
| RBC Capital | Maintained | Outperform | 110 | 2026-08-06 |
| Bernstein | Maintained | Market Perform | 93 | 2026-08-06 |
| Stifel | Maintained | Buy | 110 | 2026-08-06 |
| BMO Capital | Initiated | Market Perform | 95 | 2026-07-09 |
| Evercore ISI Group | Maintained | Outperform | 110 | 2026-07-06 |
| Citigroup | Maintained | Neutral | 93 | 2026-05-28 |
| JP Morgan | Maintained | Neutral | 95 | 2026-04-29 |
| Citigroup | Maintained | Neutral | 95 | 2026-04-29 |
| Citizens | Maintained | Market Outperform | 105 | 2026-04-29 |
Firm rows and rating mix from Yahoo Finance; mean target is Yahoo’s aggregate until OpenFilings derives consensus from broker rows.